Costa Tânia, Linhares Inês, Ferreira Ricardo, Neves Jasmin, Almeida Adelaide
1 Department of Biology and CESAM, University of Aveiro , Aveiro, Portugal .
2 Centro Médico da Praça Lda , São João da Madeira, Portugal .
Microb Drug Resist. 2018 May;24(4):493-504. doi: 10.1089/mdr.2016.0318. Epub 2017 Sep 18.
The present study aims to evaluate the predominance of uropathogens responsible for urinary tract infection (UTI) and determine their resistance patterns, to assess if the recommended empirical treatment is appropriate for the studied population. Samples were collected in Aveiro (Portugal) from an ambulatory service between June 2011 and June 2014.
From the 4,270 positive urine samples for UTI, 3,561 (83%) were from women and only 709 (17%) were from men. The bacterium Escherichia coli was the most frequent uropathogen, followed by Klebsiella sp., Enterococcus sp., and Proteus mirabilis. E. coli was also the uropathogen presenting less resistance to antibiotics, including those recommended as first and second line UTI treatment. In general, bacteria isolated from men were more resistant to antimicrobials than bacteria isolated from women.
The results of this study emphasized the relevance to consider sex as a differentiating factor in the choice of UTI empirical treatment, mainly due to differences in antimicrobial resistance. From the first line drugs recommended by the European Association of Urology (EAU) to empirical treatment of uncomplicated UTI, nitrofurantoin is the most appropriate drug for both sexes. Ciprofloxacin, although appropriate for treatment in women, is not appropriate to treat UTIs in men. From the second line drugs, both trimethoprim-sulfamethoxazole (TMP-SMX) and amoxicillin-clavulanic acid (AMX-CA) are appropriate drugs for treatment of uncomplicated UTI in women, but not as effective for men.
本研究旨在评估引起尿路感染(UTI)的尿路病原体的优势情况,并确定其耐药模式,以评估推荐的经验性治疗对所研究人群是否合适。样本于2011年6月至2014年6月在葡萄牙阿威罗的一家门诊服务机构收集。
在4270份UTI阳性尿液样本中,3561份(83%)来自女性,仅709份(17%)来自男性。大肠杆菌是最常见的尿路病原体,其次是克雷伯菌属、肠球菌属和奇异变形杆菌。大肠杆菌也是对抗生素耐药性较低的尿路病原体,包括那些被推荐作为UTI一线和二线治疗的抗生素。总体而言,从男性分离出的细菌比从女性分离出的细菌对抗菌药物的耐药性更强。
本研究结果强调在选择UTI经验性治疗时将性别作为一个区分因素的相关性,主要是由于抗菌药物耐药性的差异。从欧洲泌尿外科学会(EAU)推荐用于非复杂性UTI经验性治疗的一线药物来看,呋喃妥因对两性都是最合适的药物。环丙沙星虽然适合女性治疗,但不适合治疗男性的UTI。从二线药物来看,甲氧苄啶-磺胺甲恶唑(TMP-SMX)和阿莫西林-克拉维酸(AMX-CA)都是治疗女性非复杂性UTI的合适药物,但对男性的效果不佳。